Updated: Dec 14, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Takahiro Sasaki1, Akira Miyauchi2, Yasuhiro Ito2
1Department of Head and Neck Surgery, Kuma Hospital, Kobe, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Active surveillance for papillary microcarcinoma (PMC) is safe. Fewer patients converted to surgery in recent years, likely due to increased physician confidence and patient trust in active surveillance outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: